Total Payments
$4,679
2024 Payments
$502.78
Companies
17
Transactions
200
Medicare Patients
1,940
Medicare Billing
$200,937
Payment Breakdown by Category
Food & Beverage$4,679 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,679 | 200 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,946 | 71 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $456.92 | 20 | $0 (2023) |
| Janssen Biotech, Inc. | $367.55 | 22 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $340.61 | 19 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $311.97 | 3 | $0 (2022) |
| Celgene Corporation | $286.47 | 16 | $0 (2023) |
| PFIZER INC. | $284.49 | 18 | $0 (2023) |
| Ipsen Biopharmaceuticals, Inc | $125.00 | 1 | $0 (2024) |
| GENZYME CORPORATION | $120.54 | 5 | $0 (2023) |
| VIVUS LLC | $87.97 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $502.78 | 4 | ABBVIE INC. ($377.78) |
| 2023 | $1,022 | 39 | ABBVIE INC. ($533.16) |
| 2022 | $2,290 | 110 | ABBVIE INC. ($726.31) |
| 2021 | $863.46 | 47 | AbbVie Inc. ($308.32) |
All Payment Transactions
200 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $124.95 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $124.95 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Rare Disease | ||||||
| 02/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $127.88 | General |
| Category: IMMUNOLOGY | ||||||
| 12/14/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $105.86 | General |
| Category: IMMUNOLOGY | ||||||
| 11/09/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $112.50 | General |
| Category: IMMUNOLOGY | ||||||
| 06/07/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $124.13 | General |
| Category: IMMUNOLOGY | ||||||
| 05/03/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Gastroenterology | ||||||
| 04/18/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Gastroenterology | ||||||
| 04/13/2023 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/12/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Gastroenterology | ||||||
| 03/29/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.91 | General |
| Category: Neuroscience | ||||||
| 03/27/2023 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/23/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: IMMUNOLOGY | ||||||
| 03/23/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/21/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Immunology | ||||||
| 03/15/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/15/2023 | ABBVIE INC. | RINVOQ (Biological), HUMIRA | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: IMMUNOLOGY | ||||||
| 03/14/2023 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/09/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/08/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: Immunology | ||||||
| 03/07/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Gastroenterology | ||||||
| 03/06/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 03/06/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Gastroenterology | ||||||
| 03/03/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 514 | 640 | $189,956 | $56,791 |
| 2022 | 5 | 481 | 711 | $184,422 | $56,481 |
| 2021 | 4 | 484 | 658 | $158,859 | $49,523 |
| 2020 | 3 | 461 | 592 | $124,025 | $38,143 |
Total Patients
1,940
Total Services
2,601
Medicare Billing
$200,937
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 262 | 343 | $87,525 | $26,615 | 30.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 162 | 207 | $74,289 | $22,117 | 29.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 50 | 50 | $16,748 | $4,449 | 26.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $7,068 | $2,345 | 33.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 24 | $4,326 | $1,264 | 29.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 333 | 560 | $143,484 | $44,073 | 30.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 61 | 61 | $20,623 | $6,114 | 29.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 54 | 57 | $10,377 | $3,049 | 29.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 18 | 18 | $6,534 | $2,182 | 33.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 15 | 15 | $3,404 | $1,063 | 31.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 271 | 422 | $108,903 | $34,841 | 32.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 158 | 181 | $32,562 | $9,401 | 28.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 44 | 44 | $14,908 | $4,505 | 30.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 11 | 11 | $2,486 | $776.50 | 31.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 312 | 433 | $94,013 | $28,915 | 30.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 115 | 125 | $18,750 | $6,265 | 33.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 34 | 34 | $11,262 | $2,963 | 26.3% |
About Guilene Davilmar, ARNP
Guilene Davilmar, ARNP is a Adult Health healthcare provider based in Melbourne, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2017. The National Provider Identifier (NPI) number assigned to this provider is 1669994083.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Guilene Davilmar, ARNP has received a total of $4,679 in payments from pharmaceutical and medical device companies, with $502.78 received in 2024. These payments were reported across 200 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($4,679).
As a Medicare-enrolled provider, Davilmar has provided services to 1,940 Medicare beneficiaries, totaling 2,601 services with total Medicare billing of $200,937. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Adult Health
- Other Specialties Family, Nurse Practitioner
- Location Melbourne, FL
- Active Since 07/07/2017
- Last Updated 04/27/2018
- Taxonomy Code 363LA2200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1669994083
Products in Payments
- SKYRIZI (Biological) $632.57
- RINVOQ (Biological) $614.05
- ZEPOSIA (Drug) $494.04
- ENTYVIO (Biological) $372.13
- XIFAXAN (Drug) $305.37
- XELJANZ (Drug) $284.49
- STELARA (Biological) $242.34
- HUMIRA (Biological) $210.47
- CREON (Drug) $191.85
- DUPIXENT (Biological) $181.87
- LINZESS (Drug) $181.31
- REMICADE (Biological) $125.21
- IQIRVO (Drug) $125.00
- MAVYRET (Drug) $100.84
- ZENPEP (Drug) $75.57
- GATTEX (Drug) $70.99
- DIFICID (Drug) $62.59
- PANCREAZE (Drug) $55.18
- OCALIVA (Drug) $40.87
- TRULANCE (Drug) $35.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adult Health Doctors in Melbourne
Ms. Melissa Studebaker, Arnp-C, ARNP-C
Adult Health — Payments: $13,705
Adult Health $13,705
Cynthia Furlan, Aprn, APRN
Adult Health — Payments: $7,791
Adult Health $7,791
Melissa Frank, Arnp, ARNP
Adult Health — Payments: $7,554
Adult Health $7,554
Felmer Stewart, Aprn, APRN
Adult Health — Payments: $6,342
Adult Health $6,342
Doris Thornhill, Aprn, APRN
Adult Health — Payments: $5,877
Adult Health $5,877
Michele Mccarthy-Lavish, Aprn, APRN
Adult Health — Payments: $4,456
Adult Health $4,456